STRIGARI, LIDIA
STRIGARI, LIDIA
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
2019 Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P.
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis
2021 Botticelli, A.; Cirillo, A.; Strigari, L.; Valentini, F.; Cerbelli, B.; Scagnoli, S.; Cerbelli, E.; Zizzari, I. G.; Della Rocca, C.; D'Amati, G.; Polimeni, A.; Nuti, M.; Merlano, M. C.; Mezi, S.; Marchetti, P.
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
2024 Gelibter, Alain; Asquino, Angela; Strigari, Lidia; Zizzari, Ilaria; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Siringo, Marco; Tramontano, Elisa; Bianchini, Serena; Bellati, Filippo; Botticelli, Andrea; Paoli, Donatella; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Cerebrospinal fluid leaks after anterior skull base trauma: a systematic review of the literature
2022 Umana, Giuseppe E.; Pucci, Resi; Palmisciano, Paolo; Cassoni, Andrea; Ricciardi, Luca; Tomasi, Santino O.; Strigari, Lidia; Scalia, Gianluca; Valentini, Valentino
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients
2022 Zizzari, Ig; Di Filippo, A; Botticelli, A; Strigari, L; Pernazza, A; Rullo, E; Pignataro, Mg; Ugolini, A; Scirocchi, F; DI PIETRO, FRANCESCA ROMANA; Rossi, E; Gelibter, A; Schinzari, G; D'Amati, G; Rughetti, A; Marchetti, P; Nuti, M; Napoletano, C.
Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients
2023 Cirillo, Alessio; Zizzari, ILARIA GRAZIA; Botticelli, Andrea; Strigari, Lidia; Asquino, Angela; RAHIMI KOSHKAKI, Hassan; Scagnoli, Simone; Scirocchi, Fabio; Pernazza, Angelina; Pace, Angelica; Cerbelli, Bruna; D'Amati, Giulia; Marchetti, Paolo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients
2023 Cirillo, Alessio; Zizzari, ILARIA GRAZIA; Botticelli, Andrea; Strigari, Lidia; RAHIMI KOSHKAKI, Hassan; Scagnoli, Simone; Scirocchi, Fabio; Pernazza, Angelina; Pace, Angelica; Cerbelli, Bruna; D'Amati, Giulia; Marchetti, Paolo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment
2024 Asquino, Angela; Pace, Angelica; Cirillo, Alessio; Strigari, Lidia; Napoletano, Chiara; Scirocchi, Fabio; Nuti, Marianna; Santini, Daniele; Botticelli, Andrea; Rughetti, Aurelia; Zizzari, ILARIA GRAZIA
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study
2024 Scagnoli, Simone; Pisegna, Simona; Toss, Angela; Caputo, Roberta; De Laurentiis, Michelino; Palleschi, Michela; de Giorgi, Ugo; Cortesi, Enrico; Fabbri, Agnese; Fabi, Alessandra; Paris, Ida; Orlandi, Armando; Curigliano, Giuseppe; Criscitiello, Carmen; Garrone, Ornella; Tomasello, Gianluca; D'Auria, Giuliana; Vici, Patrizia; Ricevuto, Enrico; Domati, Federica; Piombino, Claudia; Parola, Sara; Scafetta, Roberta; Cirillo, Alessio; TAURELLI SALIMBENI, Beatrice; DI LISA, FRANCESCA SOFIA; Strigari, Lidia; Preissner, Robert; Simmaco, Maurizio; Santini, Daniele; Marchetti, Paolo; Botticelli, Andrea
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells
2020 Ugolini, A; Zizzari, Ig; Ceccarelli, F; Botticelli, A; Colasanti, T; Strigari, L; Rughetti, A; Rahimi, H; Conti, F; Valesini, G; Marchetti, P; Nuti, M
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells
2020 Ugolini, Alessio; Zizzari, ILARIA GRAZIA; Ceccarelli, Fulvia; Botticelli, Andrea; Colasanti, Tania; Strigari, Lidia; Rughetti, Aurelia; RAHIMI KOSHKAKI, Hassan; Conti, Fabrizio; Valesini, Guido; Marchetti, Paolo; Nuti, Marianna
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response
2022 Scirocchi, Fabio; Scagnoli, Simone; Botticelli, Andrea; Di Filippo, Alessandra; Napoletano, Chiara; Zizzari, Ilaria Grazia; Strigari, Lidia; Tomao, Silverio; Cortesi, Enrico; Rughetti, Aurelia; Marchetti, Paolo; Nuti, Marianna
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study
2018 Barnabei, Agnese; Strigari, Lidia; Persichetti, Agnese; Baldelli, Roberto; Rizza, Laura; Annoscia, Claudia; Lauretta, Rosa; Cigliana, Giovanni; Barba, Maddalena; De Leo, Aurora; Appetecchia, Marialuisa; Torino, Francesco
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines
2018 Mazzuca, Federica; Onesti, Concetta Elisa; Roberto, Michela; Di Girolamo, Marco; Botticelli, Andrea; Begini, Paola; Strigari, Lidia; Marchetti, Paolo; Muscaritoli, Maurizio
Novel circulating biomarkers in HNSCC patients receiving anti-PD1 therapy: the predictive and prognostic role of immunosuppressive CD137+Treg cells and Lox-1+PMN-MDSCs
2024 Asquino, A.; Cirillo, A.; Strigari, L.; Pace, A.; Napoletano, C.; Tuosto, L.; Valentino, F.; Santini, D.; Nuti, M.; Botticelli, A.; Rughetti, A.; Zizzari, I. G.
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival
2018 Roberto, Michela; Botticelli, Andrea; Strigari, Lidia; Ghidini, Michele; Onesti, Concetta Elisa; Ratti, Margherita; Benzoni, Ilaria; Pizzo, Claudio; Falcone, Rosa; Lomiento, Daniele; Donida, Bianca Maria; Totaro, Luigi; Mazzuca, Federica; Marchetti, Paolo
Response to: comment on “Impact of tumor site on the prognosis of small bowel adenocarcinoma”
2019 Falcone, R.; Strigari, L.; Farina, L.; Marchetti, P.
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis
2022 Scirocchi, Fabio; Strigari, Lidia; DI FILIPPO, Alessandra; Napoletano, Chiara; Pace, Angelica; RAHIMI KOSHKAKI, Hassan; Botticelli, Andrea; Rughetti, Aurelia; Nuti, Marianna; Zizzari, ILARIA GRAZIA
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy
2020 Botticelli, A.; Cirillo, A.; Scagnoli, S.; Cerbelli, B.; Strigari, L.; Cortellini, A.; Pizzuti, L.; Vici, P.; De Galitiis, F.; Di Pietro, F. R.; Cerbelli, E.; Ghidini, M.; D'Amati, G.; Rocca, C. D.; Mezi, S.; Gelibter, A.; Giusti, R.; Cortesi, E.; Ascierto, P. A.; Nuti, M.; Marchetti, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab | 2019 | Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P. | |
| Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis | 2021 | Botticelli, A.; Cirillo, A.; Strigari, L.; Valentini, F.; Cerbelli, B.; Scagnoli, S.; Cerbelli, E.; Zizzari, I. G.; Della Rocca, C.; D'Amati, G.; Polimeni, A.; Nuti, M.; Merlano, M. C.; Mezi, S.; Marchetti, P. | |
| CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line | 2024 | Gelibter, Alain; Asquino, Angela; Strigari, Lidia; Zizzari, Ilaria; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Siringo, Marco; Tramontano, Elisa; Bianchini, Serena; Bellati, Filippo; Botticelli, Andrea; Paoli, Donatella; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Cerebrospinal fluid leaks after anterior skull base trauma: a systematic review of the literature | 2022 | Umana, Giuseppe E.; Pucci, Resi; Palmisciano, Paolo; Cassoni, Andrea; Ricciardi, Luca; Tomasi, Santino O.; Strigari, Lidia; Scalia, Gianluca; Valentini, Valentino | |
| Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients | 2022 | Zizzari, Ig; Di Filippo, A; Botticelli, A; Strigari, L; Pernazza, A; Rullo, E; Pignataro, Mg; Ugolini, A; Scirocchi, F; DI PIETRO, FRANCESCA ROMANA; Rossi, E; Gelibter, A; Schinzari, G; D'Amati, G; Rughetti, A; Marchetti, P; Nuti, M; Napoletano, C. | |
| Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients | 2023 | Cirillo, Alessio; Zizzari, ILARIA GRAZIA; Botticelli, Andrea; Strigari, Lidia; Asquino, Angela; RAHIMI KOSHKAKI, Hassan; Scagnoli, Simone; Scirocchi, Fabio; Pernazza, Angelina; Pace, Angelica; Cerbelli, Bruna; D'Amati, Giulia; Marchetti, Paolo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients | 2023 | Cirillo, Alessio; Zizzari, ILARIA GRAZIA; Botticelli, Andrea; Strigari, Lidia; RAHIMI KOSHKAKI, Hassan; Scagnoli, Simone; Scirocchi, Fabio; Pernazza, Angelina; Pace, Angelica; Cerbelli, Bruna; D'Amati, Giulia; Marchetti, Paolo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment | 2024 | Asquino, Angela; Pace, Angelica; Cirillo, Alessio; Strigari, Lidia; Napoletano, Chiara; Scirocchi, Fabio; Nuti, Marianna; Santini, Daniele; Botticelli, Andrea; Rughetti, Aurelia; Zizzari, ILARIA GRAZIA | |
| Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study | 2024 | Scagnoli, Simone; Pisegna, Simona; Toss, Angela; Caputo, Roberta; De Laurentiis, Michelino; Palleschi, Michela; de Giorgi, Ugo; Cortesi, Enrico; Fabbri, Agnese; Fabi, Alessandra; Paris, Ida; Orlandi, Armando; Curigliano, Giuseppe; Criscitiello, Carmen; Garrone, Ornella; Tomasello, Gianluca; D'Auria, Giuliana; Vici, Patrizia; Ricevuto, Enrico; Domati, Federica; Piombino, Claudia; Parola, Sara; Scafetta, Roberta; Cirillo, Alessio; TAURELLI SALIMBENI, Beatrice; DI LISA, FRANCESCA SOFIA; Strigari, Lidia; Preissner, Robert; Simmaco, Maurizio; Santini, Daniele; Marchetti, Paolo; Botticelli, Andrea | |
| Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial | 2020 | Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo | |
| IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells | 2020 | Ugolini, A; Zizzari, Ig; Ceccarelli, F; Botticelli, A; Colasanti, T; Strigari, L; Rughetti, A; Rahimi, H; Conti, F; Valesini, G; Marchetti, P; Nuti, M | |
| IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells | 2020 | Ugolini, Alessio; Zizzari, ILARIA GRAZIA; Ceccarelli, Fulvia; Botticelli, Andrea; Colasanti, Tania; Strigari, Lidia; Rughetti, Aurelia; RAHIMI KOSHKAKI, Hassan; Conti, Fabrizio; Valesini, Guido; Marchetti, Paolo; Nuti, Marianna | |
| Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response | 2022 | Scirocchi, Fabio; Scagnoli, Simone; Botticelli, Andrea; Di Filippo, Alessandra; Napoletano, Chiara; Zizzari, Ilaria Grazia; Strigari, Lidia; Tomao, Silverio; Cortesi, Enrico; Rughetti, Aurelia; Marchetti, Paolo; Nuti, Marianna | |
| Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study | 2018 | Barnabei, Agnese; Strigari, Lidia; Persichetti, Agnese; Baldelli, Roberto; Rizza, Laura; Annoscia, Claudia; Lauretta, Rosa; Cigliana, Giovanni; Barba, Maddalena; De Leo, Aurora; Appetecchia, Marialuisa; Torino, Francesco | |
| Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines | 2018 | Mazzuca, Federica; Onesti, Concetta Elisa; Roberto, Michela; Di Girolamo, Marco; Botticelli, Andrea; Begini, Paola; Strigari, Lidia; Marchetti, Paolo; Muscaritoli, Maurizio | |
| Novel circulating biomarkers in HNSCC patients receiving anti-PD1 therapy: the predictive and prognostic role of immunosuppressive CD137+Treg cells and Lox-1+PMN-MDSCs | 2024 | Asquino, A.; Cirillo, A.; Strigari, L.; Pace, A.; Napoletano, C.; Tuosto, L.; Valentino, F.; Santini, D.; Nuti, M.; Botticelli, A.; Rughetti, A.; Zizzari, I. G. | |
| Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival | 2018 | Roberto, Michela; Botticelli, Andrea; Strigari, Lidia; Ghidini, Michele; Onesti, Concetta Elisa; Ratti, Margherita; Benzoni, Ilaria; Pizzo, Claudio; Falcone, Rosa; Lomiento, Daniele; Donida, Bianca Maria; Totaro, Luigi; Mazzuca, Federica; Marchetti, Paolo | |
| Response to: comment on “Impact of tumor site on the prognosis of small bowel adenocarcinoma” | 2019 | Falcone, R.; Strigari, L.; Farina, L.; Marchetti, P. | |
| Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis | 2022 | Scirocchi, Fabio; Strigari, Lidia; DI FILIPPO, Alessandra; Napoletano, Chiara; Pace, Angelica; RAHIMI KOSHKAKI, Hassan; Botticelli, Andrea; Rughetti, Aurelia; Nuti, Marianna; Zizzari, ILARIA GRAZIA | |
| The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy | 2020 | Botticelli, A.; Cirillo, A.; Scagnoli, S.; Cerbelli, B.; Strigari, L.; Cortellini, A.; Pizzuti, L.; Vici, P.; De Galitiis, F.; Di Pietro, F. R.; Cerbelli, E.; Ghidini, M.; D'Amati, G.; Rocca, C. D.; Mezi, S.; Gelibter, A.; Giusti, R.; Cortesi, E.; Ascierto, P. A.; Nuti, M.; Marchetti, P. |